Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Principles and practical applications of structure-based vaccine design
Patrick O. Byrne, Jason S. McLellan
Current Opinion in Immunology (2022) Vol. 77, pp. 102209-102209
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Breathing and Tilting: Mesoscale Simulations Illuminate Influenza Glycoprotein Vulnerabilities
Lorenzo Casalino, Christian Seitz, Julia Lederhofer, et al.
ACS Central Science (2022) Vol. 8, Iss. 12, pp. 1646-1663
Open Access | Times Cited: 37
Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer
Javad Sarvmeili, Bahram Baghban Kohnehrouz, Ashraf Gholizadeh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
One Health Approach to the Computational Design of a Lipoprotein-Based Multi-Epitope Vaccine Against Human and Livestock Tuberculosis
Robert Adamu Shey, Gordon Takop Nchanji, Tangan Yanick Aqua Stong, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1587-1587
Open Access
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies
Taylor B. Engdahl, Elad Binshtein, Rebecca L. Brocato, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 17
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
Lucy Rutten, Maarten Swart, Annemart Koornneef, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Computational design of vaccine immunogens
Karla M. Castro, Andreas Scheck, Shuhao Xiao, et al.
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102821-102821
Open Access | Times Cited: 19
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
James A. Williams, Marco Biancucci, Laura N. Lessen, et al.
Science Advances (2023) Vol. 9, Iss. 23
Open Access | Times Cited: 10
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 3
Neutralising antibodies against human metapneumovirus
Lei Guo, Li Li, Liu Li, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e732-e744
Open Access | Times Cited: 8
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
Brian G. Pierce, Nathaniel Felbinger, Matthew C. Metcalf, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 803-803
Open Access | Times Cited: 2
Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody
Robert Stass, Taylor B. Engdahl, Nathaniel S. Chapman, et al.
Nature Microbiology (2023) Vol. 8, Iss. 7, pp. 1293-1303
Open Access | Times Cited: 7
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
Brian G. Pierce, Nathaniel Felbinger, Mathew Metcalf, et al.
(2024)
Open Access | Times Cited: 1
Beta Spike-Presenting SARS-CoV-2 Virus-Like Particle Vaccine Confers Broad Protection against Other VOCs in Mice
Irfan Ullah, Kelly Symmes, Kadiatou Keita, et al.
(2024)
Open Access | Times Cited: 1
In silico design and analysis of a multiepitope vaccine against Chlamydia
Tayhlor Tanner, Fnu Medhavi, Shakyra Richardson, et al.
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 1
Structural basis for potent neutralization of human respirovirus type 3 by protective single-domain camelid antibodies
Nicole V. Johnson, Revina C. van Scherpenzeel, Mark J. G. Bakkers, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses
Mark J. G. Bakkers, Freek Cox, Annemart Koornneef, et al.
Nature Microbiology (2024)
Open Access | Times Cited: 1
Free Energy Simulations of Receptor-Binding Domain Opening of the SARS-CoV-2 Spike Indicate a Barrierless Transition with Slow Conformational Motions
Victor Ovchinnikov, Martin Karplus
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8565-8575
Open Access | Times Cited: 3
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
High-Accuracy Prediction of Stabilizing Surface Mutations to the Three-Helix Bundle, UBA(1), with EmCAST
Michael T. Rothfuss, Dustin C. Becht, Baisen Zeng, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 42, pp. 22979-22992
Closed Access | Times Cited: 2
Finally neutralizing the threat? A novel SARS-CoV-2 vaccine platform that elicits enhanced neutralizing antibody responses
Daniel J. Salamango
mBio (2024) Vol. 15, Iss. 4
Open Access
Update on Hepatitis C Vaccine: Results and Challenges
Anna Rosa Garbuglia, Silvia Pauciullo, Verdiana Zulian, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1337-1337
Open Access
Mechanistic insights into structure-based design of a Lyme disease subunit vaccine
Kalvis Brangulis, Jill Malfetano, Ashley L. Marcinkiewicz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top